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ABSTRACT
Objective: The aim of this study was to compare the quantity and quality of drug utilization (DU) in patients with respiratory problems at a hospital 
in Indonesia before and after the implementation of the national formulary.
Methods: A cross-sectional retrospective study was conducted in 2013 and 2015 at the Depok Hospital in Indonesia. Prescriptions and data from 
patients were recapitulated, reviewed, and evaluated using the anatomical therapeutical chemical classification/defined daily doses (DDDs) and 
DU90% methodologies. The results were statistically analyzed and compared before and after implementation of the national formulary.
Results: The quantity of drug use in DDD/1000 inhabitant per day was increased from 0.17 to 0.26 between 2013 and 2015. The quality of drug 
use was also increased following a decrease in the number of drugs in the DU90% segment. The percentage of drugs that adhered to the national 
formulary was 88.67%; however, no significant difference was noted before and after the implementation of the national formulary.
Conclusion: The quantity, quality, and adherence of drug use to the national formulary was increased at the Depok city hospital after the implementation 
of the national formulary.
Keywords: Anatomical therapeutic chemical/defined daily doses, Depok hospital, Drug utilization, National formulary.
INTRODUCTION
National formulary was first applied as prescribing guidance for 
national health insurance in 2014 [1]. The national formulary comprises 
lists of essential drugs specific for health care and is widely used to 
promote rational pharmacotherapy [1]. Formularies are developed 
and implemented as management tools in primary health care and 
hospitals [2].
Respiratory disease is common in Indonesia. On the basis of basic 
health research report in 2013, the prevalence of respiratory disease 
in Indonesia is approximately 25%, and infants are the most affected 
(>35%). The high prevalence, as well as variations of this disease, 
can affect the pattern of drug use in health facilities. Respiratory 
diseases can be categorized as rhinitis, sinusitis, pharyngitis, laryngitis, 
epiglottis, and tonsillitis, based on the region affected; bronchitis, 
bronchiolitis, and pneumonia occur when the lower parts of the body 
are affected by the disease [3].
In 1981, the World Health Organization (WHO) recommended the 
anatomical therapeutic chemical/defined daily doses (ATC/DDDs) 
method as an international standard for drug utilization (DU) studies. 
The method was employed to evaluate the use of medicines and to 
detect any early signals of their irrational use. This method can be 
combined with the DU 90% method to identify the high use segment 
of medicine [4].
DU 90% prescribing profiles have been proven valuable in general 
practice for assessing the overall prescribing quality. DU 90% identifies 
drugs constituting 90% of the prescribed volume in DDDs and the 
adherence to the guidelines within this segment. It includes all the 
different drugs prescribed, and may, therefore, be useful for assessing the 
quality of drug prescription in hospitals [4,5]. The quality of prescribing 
drug and adherence to guidelines have been evaluated at different levels 
(hospital and primary care); a large diversity in the manner in which 
drugs are selected in the formulary and the methods used to develop 
and implement the formulary have been reported [2,5-7].
In the current study, we aimed to compare the quantity and quality of 
DU in patients with respiratory problems at a hospital in Indonesia 
before and after the implementation of the national formulary.
METHODS
This cross-sectional study was conducted in 2013 and 2015 at the 
Depok city hospital, in Indonesia. Data of drugs used at the hospital 
during the years 2013 and 2015 were obtained retrospectively from 
the pharmacy database. The survey included 11 types of respiratory 
diseases diagnosed at the hospital. Prescriptions for patients diagnosed 
with common cold, pharyngitis, tonsillitis, acute respiratory infection, 
bronchopneumonia, bronchitis, bronchiolitis, rhinitis, sinusitis, asthma, 
and bronchiectasis were included in this study. Prescriptions, treatment 
books, and patient data regarding respiratory diseases during the years 
2013 and 2015 were reviewed and evaluated. The drugs included in 
the study were antihistamines, antimycobacterial, corticosteroids, 
nonsteroidal anti-inflammatory drugs, antipyretics, analgesics, 
respiratory drugs, medicines for cold and cough, and vitamins.
Data were collected and calculated as DDD/1000 inhabitants/day based 
on the ATC/DDD guidelines [3]. The total amount for each drug was 
converted to grams and calculated by multiplying the total number of 
drugs with the total amount in DDD units. The total amount of each drug 
in DDD units was calculated by dividing the total amount of drugs in 
grams by the DDD values of the drugs, as described on the WHO website. 
DDD is a technical unit based on the assumed average maintenance dose 
per day for a drug used for its main indication in adults. >1 DDD given to 
an adult patient per day could be viewed as an indication of overuse, and 
the data can be used as a signal for irrational use.
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The DDD/1000 inhabitants/year was calculated by dividing the total 
consumption in 1 year (DDD units) by the total number of visiting 
patients during the 1-year period divided by 1000; this can be divided 
by 365 to calculate the DDD/1000 patients/day. For example, the figure 
of 10 DDDs/1000 patients/day for amoxicillin (J01CAO4) indicates 
that 10 out of 1000 patients (or 1%) may have theoretically received a 
standard dose of amoxicillin (1 g every day).
Data regarding the number of patients and patterns of diseases 
were obtained from the total number of patients who visited the 
hospital and the disease report published by the district health office, 
respectively. Population data were obtained from the census data in 
2013 and 2015.
Data on drug use were analyzed using descriptive statistics, and the 
most used drug segment was identified by the DU 90% method. The 
drugs were ranked by the volume of DDDs and those drugs accounted 
for 90% of the total volume, that is, the DU 90%.
SPSS software was used for statistical analyses, with p<0.05 considered 
significant. Non-parametric and parametric tests were performed 
to compare the quantity and quality of the drugs used. Adherence to 
prescription in 2015 was used for descriptive analyses.
RESULTS
Prescriptions were collected from patients who were diagnosed with 
11 types of respiratory diseases using the International Statistical 
Classification of Disease and Related Health Problems, 42 and 46 types 
of drugs were used for the patients in 2013 and 2015, respectively 
(Tables 1-3). However, the ratios of drug consumption among 
the respiratory patients in 2013 and 2015 were 0.16 DDD/1000 
inhabitants/day and 0.25 DDD/1000 inhabitants/day, respectively 
(p>0.05).
As shown in Table 4, the DU 90% of 14 out of 42 types of drugs and 11 
out of 46 drugs were obtained in 2013 and 2015, respectively. Drugs 
with the highest DU 90% in 2013 were salbutamol (42.06%), Vitamin C 
(9.51%), and chlorpheniramine maleate (8.03%) and in 2015 were 
salbutamol (35.90%), Vitamin B complex (15.38%), and cetirizine 
(12.78%). No significant difference in DU 90% between the 2 years was 
noted (p>0.05).
It was found that the drug adherence of 47 types of drugs (88.67%) and 
six types of drug in Depok city hospital were not included in national 
formulary. The drugs that were not included were thiamphenicol, 
kalium diclofenac, pseudoephedrine, glyceryl guaiacolate, ambroxol, 
and dextromethorphan.
DISCUSSION
The findings of the present study indicated the presence of variations 
in prescriptions for different respiratory problems. The formulary is 
Table 1: Prescriptions in 2013 and 2015 at Depok city hospital
Diagnosis 2013 2015
Rhinitis 1269 1761 
Bronchitis 1185 1585 
Asthma 1054 993 
ARTI 775 999 
Bronchopneumonia 463 798 
Pharyngitis 516 166 
Bronchiectasis 296 347 
Tonsillitis 49 34 
Common cold 21 16 
Bronchiolitis 4 0 
Sinusitis 3 0
Total prescription 5635 6699 
Table 2: Population and drug consumption at Depok city 
hospital
Information 2013 2015
Population (inhabitant) 716, 188, 400 742, 230, 420
Drug consumption (DDD) 206, 651.30 231, 056.6
Drug consumption  
(DDD/1000 inhabitant/day)
0.16 0.25






39 J01MA12 Levofloxacin 0.0000698 0.0000000
40 N02AX02 Tramadol 0.0000163 0.0000106
41 R05CB02 Bromhexine 0.0000056 0.0000539
42 J01BA01 Chloramphenicol 0.0000023 0.0000022
43 R01AD12 Fluticasone furoate 0 0.0158846
44 R03AC04 Fenoterol HBr 0 0.0000898
45 R03AK06 Fluticasone propionate 0 0.0015763
46 R03BA07 Mometasone furoate 0 0.0003772
Total 0.1683201 0.255475







1 R03AC02 Salbutamol 0.0707884 0.0917138
2 A11GA01 Vitamin C 0.0160150 0.0010532
3 R06AB02 Chlorpheniramine maleate 0.0135113 0.0023973
4 A11EA Vitamin B complex 0.0115919 0.0392870
5 B03BA01 Cyanocobalamin 0.0063092 0.0001867
6 H02AB02 Dexamethasone 0.0046626 0.0030404
7 J04AC01 Isoniazid 0.0046417 0.0071698
8 A11DA01 Thiamine 0.0040855 0.0002398
9 R05CB06 Ambroxol 0.0037790 0.0109552
10 R03BA02 Budesonide 0.0033214 0.0024639
11 J01MA02 Ciprofloxacin 0.0032212 0.0021105
12 N02BE01 Paracetamol 0.0029292 0.0026081
13 H02AB04 Methylprednisolone 0.0028320 0.0038155
14 J04AB02 Rifampicin 0.0027357 0.0044885
15 R05CA03 Glyceryl guaiacolate 0.0026734 0.0012063
16 J01DB05 Cefadroxil 0.0020560 0.0014672
17 R06AX13 Loratadine 0.0017118 0.0001751
18 J01DD08 Cefixime 0.0015415 0.0037556
19 J01CR02 Amoxicillin clavulanic 0.0014199 0.0029817
20 J01CA04 Amoxicillin 0.0013778 0.0005841
21 R06AE07 Cetirizine 0.0013711 0.0326516
22 J04AK01 Pyrazinamide 0.0011073 0.0015260
23 A11HA02 Pyridoxine 0.0007112 0.0007270
24 R03DA04 Theophylline 0.0006964 0.0008053
25 M01AG01 Mefenamic acid 0.0006814 0.0006386
26 H02AB07 Prednisone 0.0005383 0.0004945
27 R05DA09 Dextromethorphan 0.0004301 0.0000009
28 M01AB55 Kalium diclofenac 0.0002883 0.0003025
29 M01AB55 Natrium diclofenac 0.0001892 0.0003065
30 H02AB08 Triamcinolone 0.0001676 0.0155183
31 J04AK02 Ethambutol 0.0001414 0.0006967
32 J01FA01 Erythromycin 0.0001292 0.0000384
33 M01AE01 Ibuprofen 0.0001266 0.0000853
34 J01EE01 Cotrimoxazole 0.0001234 0.0000261
35 R05DA04 Codeine 0.0001003 0.0000857
36 J01BA02 Thiamphenicol 0.0000759 0.0000135
37 R01BA52 Pseudoephedrine combination 0.0000742 0.0017585
38 J01FA10 Azithromycin 0.0000698 0.0001055
Table 3: Pattern of drug use in 2013 and 2015 at Depok city hospital
Table 3: (Continued)
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used to manage drug use and influence their applications in primary 
care and hospitals [1]. Depok city hospital is the intermediary health 
facility with the highest number of visiting patients in Depok city. 
This study showed that the population, rug consumption, and total 
number of prescriptions had increased over the years in Depok city 
(Tables 1 and 2).
Prescriptions for rhinitis were the highest at the hospital. Rhinitis 
is one of the most common atopic diseases and chronic disorders in 
childhood [8]. The International Study of Asthma and Allergies in 
Childhood Phase 3 reported that the prevalence rates of allergic rhinitis 
in Indonesia in children aged 6–7 years and 13–14 years were 3.6% and 
6.4%, respectively [9]. Several studies have evaluated the inflammatory 
properties of cetirizine in children and adults with allergic rhinitis [10]. 
In a previous study, children treated with cetirizine (5 mg/day for 
4 weeks) demonstrated a significant reduction in inflammatory cell 
infiltrate [11].
The most highly prescribed drug at the Depok city hospital was 
salbutamol. Salbutamol is indicated for asthma and other conditions 
associated with reversible airway obstruction. Patients with severe 
acute asthma should be given high-flow oxygen (if available) and 
a short-acting beta 2 agonist through a large-volume spacer or 
salbutamol nebulizer [12]. Thus, salbutamol is the first line of 
treatment for asthma and was the most commonly used drug at the 
hospital in this study.
Fourteen drugs were included in the DU 90% segment in the year 2013 
and 11 in 2015, with Vitamin C being the most commonly prescribed 
drug. The prophylactic use of Vitamin C does not reduce the incidence of 
common cold but decreases the duration of the illness by 8% [13]. Vitamin 
B12 was prescribed for respiratory problems and included in the DU 90% 
segment in the year 2013, in the current study. Vitamin B12 has been 
shown to maintain respiratory tract infections and decrease morbidity 
[14]. The corticosteroid dexamethasone was included among the DU 
90% drugs used in 2013 and 2015. Corticosteroids have revolutionized 
the management of certain conditions, such as asthma and croup. In some 
conditions, such as bronchiolitis or cystic fibrosis, their use is controversial 
and not routinely recommended [15]. Fluticasone furoate, indicated as a 
prophylactic drug for allergic rhinitis and asthma, was not included in the 
DU90% segment in 2013 but was included in 2015 [12].
CONCLUSION
In the present study, DU for respiratory problems was measured 
by calculating the DDD/1000 inhabitants/days and DU 90% at the 
Depok city hospital in Indonesia. DDD/1000 inhabitants were found 
to be increased in 2015, and the quality of drug use was increased 
after implementation of the national formulary. The number of 
drugs in the DU 90% segment was decreased from 11 to 14 types of 
drugs from 2013 to 2015, respectively. The adherence percentage of 
drugs in 2015 to the national formulary at the Depok city hospital 
was 88.67%.
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